Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-20-053002
Filing Date
2020-11-10
Accepted
2020-11-10 16:30:53
Documents
61
Period of Report
2020-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q vie-10q_20200930.htm 10-Q 2728254
2 EX-31.1 vie-ex311_9.htm EX-31.1 19151
3 EX-31.2 vie-ex312_7.htm EX-31.2 19359
4 EX-32.1 vie-ex321_6.htm EX-32.1 9451
5 EX-32.2 vie-ex322_8.htm EX-32.2 9878
  Complete submission text file 0001564590-20-053002.txt   6592253

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT vie-20200930.xml EX-101.INS 1089836
7 XBRL TAXONOMY EXTENSION SCHEMA vie-20200930.xsd EX-101.SCH 42388
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE vie-20200930_cal.xml EX-101.CAL 50347
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE vie-20200930_def.xml EX-101.DEF 113328
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE vie-20200930_lab.xml EX-101.LAB 327846
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE vie-20200930_pre.xml EX-101.PRE 235658
Mailing Address 1 MEDIMMUNE WAY GAITHERSBURG MD 20878
Business Address 1 MEDIMMUNE WAY GAITHERSBURG MD 20878 240-558-0038
Viela Bio, Inc. (Filer) CIK: 0001734517 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39067 | Film No.: 201301578
SIC: 2834 Pharmaceutical Preparations